Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 570,614 | 593,431 | 572,243 | 487,989 | 457,572 |
| Marketable Securities | 231,208 | 181,446 | 169,082 | 179,406 | 140,267 |
| Receivables | 86,168 | 95,259 | 109,143 | 75,949 | 97,460 |
| Inventories | 8,536 | 9,185 | 9,569 | 8,253 | 10,093 |
| Income taxes - deferred | 86,445 | 85,183 | 82,980 | 81,630 | 84,238 |
| TOTAL | $1,005,851 | $986,950 | $967,394 | $858,811 | $818,579 |
| Non-Current Assets | |||||
| PPE Net | 289,755 | 252,389 | 242,970 | 243,712 | 242,917 |
| Investments And Advances | 296,335 | 313,505 | 304,376 | 293,719 | 306,338 |
| Intangibles | 341,274 | 330,191 | 326,643 | 317,055 | 321,039 |
| Other Non-Current Assets | 50,797 | 55,741 | 55,172 | 52,328 | 49,072 |
| TOTAL | $978,161 | $951,826 | $929,161 | $906,814 | $919,366 |
| Total Assets | $1,984,012 | $1,938,776 | $1,896,555 | $1,765,625 | $1,737,945 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,898 | 11,626 | 10,312 | 7,490 | 10,695 |
| Accrued Expenses | 158,376 | 153,070 | 144,382 | 124,964 | 137,795 |
| TOTAL | $189,370 | $185,173 | $176,482 | $150,031 | $172,815 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,496 | 13,167 | 12,640 | 15,165 | 20,931 |
| Other Non-Current Liabilities | 43,294 | 47,184 | 46,032 | 45,561 | 45,152 |
| TOTAL | $62,994 | $67,439 | $66,891 | $65,824 | $65,104 |
| Total Liabilities | $252,364 | $252,612 | $243,373 | $215,855 | $237,919 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,287 | 102,127 | 102,560 | 102,138 | 101,763 |
| Common Shares | 103 | 103 | 103 | 103 | 102 |
| Retained earnings | 1,660,485 | 1,614,544 | 1,574,765 | 1,498,897 | 1,454,382 |
| Other shareholders' equity | 24,645 | 30,228 | 29,240 | 27,176 | 26,730 |
| TOTAL | $1,731,648 | $1,686,164 | $1,653,182 | $1,549,770 | $1,500,026 |
| Total Liabilities And Equity | $1,984,012 | $1,938,776 | $1,896,555 | $1,765,625 | $1,737,945 |